MLICM
EIDX

Metropolitan Life Insurance Company (MetLife)’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio EIDX Stock Details EIDX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
2020
Q4 		$397K Sell
2020
Q3 		$196K Hold
2020
Q2 		$185K Hold
2020
Q1 		$190K Hold
2019
Q4 		$222K Hold
2019
Q3 		$139K Sell
2019
Q2 		$190K Hold
2019
Q1 		$143K Buy